Answer
The safety and efficacy of vestronidase alfa have not been evaluated in patients with renal or hepatic impairment, and no alternative dose regimen is recommended for these patients.
Sources for this answer
- Mepsevii 2 mg/mL concentrate for solution for infusionUltragenyx UK · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked